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Abstract
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Management of spondylodiscitis is a challenging clinical problem requiring medical and surgical
treatment strategies. The purpose of this study was to establish a rat model of spondylodiscitis that
utilizes bioluminescent Staphylococcus aureus, thus permitting in-vivo surveillance of infection
intensity. Inocula of the bioluminescent S. aureus strain XEN36 were created in concentrations of
102 CFU/0.1 mL, 104 CFU/0.1 mL, and 106 CFU/0.1 mL. Three groups of rats were injected with
the bacteria in the most proximal intervertebral tail segment. The third most proximal tail segment
was injected with saline as a control. Bioluminescence was measured at baseline, 3 days, and
weekly for a total of 6 weeks. Detected bioluminescence for each group peaked at day three and
returned to baseline at 21 days. The average intensity was highest for the experimental group
injected with the most concentrated bacterial solution (106 CFU/0.1 mL). Radiographic analysis
revealed loss of intervertebral disc space and evidence of osseous bridging. Saline injected spaces
exhibited no decrease in intervertebral spacing as compared to distal sites. Histologic analysis
revealed neutrophilic infiltrates, destruction of the annulus fibrosus and nucleus pulposus,
destruction of vertebral endplates, and osseous bridging. Saline injected discs exhibited preserved
annulus fibrosus and nucleus pulposus on histology. This study demonstrates that injection of
bioluminescent S. aureus into the intervertebral disc of a rat tail is a viable animal model for
spondylodiscitis research. This model allows for real-time, in-vivo quantification of infection
intensity, which may decrease the number of animals required for infection studies of the
intervertebral disc.
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Introduction
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The annual incidence of spondylodiscitis is reported to be 2.2 cases per 100,0001. The
incidence, however is rising, likely due to a growing number of immunosuppressed patients,
an aging population, and the emerging epidemic of intravenous drug abuse2–4. The impact of
this condition is made worse by the fact that these patients often have a less robust
physiologic reserve5. Additionally, the indolent and nonspecific course of discitis often
delays diagnosis and therefore limits early intervention. As a result, patients hospitalized
with this condition have estimated in-hospital mortality rates as high as 10% and average
lengths of stay greater than 30 days6–10. Despite successful treatment of the infection, these
patients exhibit far lower quality of life than that of the general population, and can develop
chronic motor and sensory deficits10; 11. The combination of a compromised host and an
established infection usually requires a protracted treatment course that may include surgical
intervention.
Treatment of spondylodiscitis with conventional intravenous antibiotics is often unsuccessful
due to restricted drug penetration. The avascular nature of the intervertebral disc leads to an
immune privileged environment that permits successful seeding and persistence of bacteria.
As a result, successful antimicrobial therapy often requires high dosages for prolonged
periods of time. Despite this limitation, antibiotic treatment remains the cornerstone of
current spondylodiscitis management12–14. Prolonged infections that fail antibiotic treatment
often require operative intervention, and thus expose patients to the risks of surgery,
increasing the healthcare expenses required for successful treatment.
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The medical management of spondylodiscitis has not changed significantly in several
decades, and there is substantial potential for the development of novel treatments in this
field. Current animal models of spondylodiscitis are technically challenging, requiring
paravertebral muscle dissection, intensive anesthesia protocols, and intraoperative
fluoroscopy15–24. As a result, these models require significant expense to establish infection
and require euthanasia of the host specimen to quantify infection intensity. Recently
developed animal models of infection have focused on non-invasive methods for the
longitudinal quantification of infection intensity, with bioluminescent imaging becoming
increasingly more popular25–27. The purpose of this study was to develop a preclinical
model of spondylodiscitis that reproducibly creates an infection of the intervertebral disc
that could be quantified in-vivo utilizing bioluminescent Staphylococcus aureus. This model
obviates the need to euthanize animals at punctuated time points to study therapeutic effects.
We hypothesized that inoculation of the S. aureus strain XEN36 into the intervertebral disc
space of a Sprague-Dawley rat tail would consistently produce a sustained, non-lethal
bacterial infection that could be quantified and followed over time using the in-vivo imaging
system (IVIS) technology. Here we report successful development of this rat tail
spondylodiscitis model that permits real-time monitoring of infection intensity.
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Materials and Methods
XEN36 Inoculum Preparation
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Staphylococcus aureus is the most common cause of clinical spondylodiscitis, and therefore
we selected a bioluminescent strain of this pathogen for this model. XEN36 S. aureus
(ATCC 49525 (Perkin Elmer, Waltham, MA)) possesses a Photorhabdus luminescens
luxABCDE operon on a native plasmid, which produces a bioluminescent signal. Prior to
surgery, a sample of XEN36 stock solution was streaked onto a Remel blood agar plate
(Lenexa, KS) and incubated for 18 hours at 37° C. Eighteen hours prior to surgery, 4
colonies of XEN36 were harvested and suspended in 5 mL of brain-heart Infusion (BHI)
broth (Becton Dickinson and Co., Franklin Lakes, NJ) and again incubated at 37° C for 18
hours. Immediately prior to inoculation, the samples were centrifuged at 3,000 g for 15
minutes, the solution was decanted, and the pellet was resuspended in 10 mL of phosphate
buffered saline without magnesium or calcium (PBS). The sample was subsequently diluted
with PBS until an optical density measurement of 0.5 at 600 nanometers (BioMate 3,
Thermo Fisher Scientific, Waltham, MA) was obtained, which equates to a concentration of
1.0 × 108 colony forming units per milliliter (CFU/mL). This sample was then serially
diluted with PBS to create three separate inocula with bacterial concentrations of 102
CFU/0.1 mL, 104 CFU/0.1 mL, and 106 CFU/0.1 mL. One hundred microliters (100 μL) of
each inoculum was drawn up into 1 mL syringes and stored on ice until time of
administration.
Inoculation of Rat Intervertebral Discs
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All animal procedures were approved by our Institutional Animal Care and Use Committee.
Adult male Sprague-Dawley rats were purchased from Hilltop Lab Animals, Inc. (Scottdale,
PA) and housed in our facility’s vivarium under a 12 hour light/dark cycle. Animals were
provided access to food and water ad-libitum. Animals were given seven days to acclimate
prior to the start of the study. Eighteen animals were randomly divided into the three
inoculation groups (102 CFU/0.1 mL, 104 CFU/0.1 mL, and 106 CFU/0.1 mL). Animals
were anesthetized using inhalational isoflurane, and the absence of a corneal reflex was used
to confirm sedation. Puralube ointment was applied to both eyes and 5 mg/kg of carprofen
was administered for analgesia. Following induction, the proximal tail segment was shaved
and the three most proximal intervertebral segments distal to the coat/tail transition were
identified using palpation. Calipers were used to measure the diameter at each segment, and
half of that distance was transcribed onto the tip of a 27 gauge needle using a sterile marking
pen. This measurement was used to approximate the depth of the center of the intervertebral
disc. After prepping the injection area twice with an isopropyl alcohol swab, the sterile 27
gauge needle was inserted in the third most proximal segment beginning in the dorsolateral
position, taking care not to compromise vascular structures. After the calculated depth was
reached, 100 μL of sterile PBS was injected into the nucleus pulposus as a sterile control.
When the needle is positioned correctly, fluid flows with minimal resistance into the
intervertebral disc. Next, 100 μL of one of the three bacterial concentrations was injected
into the most proximal intervertebral disc, leaving a native intervertebral segment between
the experimental and control segments.
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In-vivo Monitoring of Infection
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The In-Vivo Imaging System (Lumina II, Perkin Elmer, Waltham, MA) and the Living
Image software was used to quantify bioluminescence and was expressed in photons/second/
centimeter2 (p/sec/cm2). Animals were imaged at 0, 3, 7, 14, 21, 28, 35, and 42 days
following injection. For these imaging sessions, animals were anesthetized using the
integrated inhalational isoflurane system, and the tails were imaged in a dorsal position.
Binning was set to large, field of view was set to D, and the capture time was 5 minutes.
Baseline radiance was determined by imaging a non-inoculated rat at the same parameters as
the infected rats.
Histological Analysis

Author Manuscript

Following euthanasia, three tissue samples of the affected tail segments from each injection
group were randomly selected for histological analysis. Using rongeurs and scalpels,
longitudinal corticotomies in the included vertebrae were created to allow infiltration of 10%
formalin fixative. Samples were decalcified in Histoperfect Rapid Cal decal solution (BBC
Biochemical, Mount Vernon, WA) until the bone was easily penetrated with a metal probe.
Samples were then processed using 10% formalin, graded alcohols, xylenes, and finally
paraffin. They were then prepared on a microtome at 5 microns and dried in a slide warming
oven overnight and later stained with hematoxylin and eosin (H&E), safranin-O and fast
green, and gram staining.
Post-Mortem Imaging

Author Manuscript

At euthanasia, one rat from each group underwent Faxitron radiographic imaging (Model
#43805N, Faxitron, Tucson, AZ) to evaluate disc space narrowing and osseous bridging. To
evaluate more fully the observed fusion characteristics at the disc segment, two animals
inoculated with 104 CFU/0.1 mL (Group 2) inoculum were imaged using microCT (SkyScan
1272, Bruker, Billerica, MA) following euthanasia.
Statistical analysis
Descriptive statistics, two way analysis of variance (ANOVA), and the Tukey post-test were
used to compare the average radiance (p/sec/cm2) emitted between the three groups of
animals and for each group at prescribed time points. Significance was set at p<0.05.

Results
IVIS Imaging

Author Manuscript

All animals survived until euthanasia and none exhibited signs of systemic infection. At day
0, Group 3 (106 CFU/0.1 mL) was the only group that exhibited a statistically significant
difference in radiance as compared to baseline (9,305 p/sec/cm2 vs. 2,900 p/sec/cm2,
p=0.0026), but by the third day following injection, all groups exhibited significant increases
in radiance from baseline (Group 1 = 12,402 p/sec/cm2, p<0.0001; Group 2 = 14,533
p/sec/cm2, p<0.0001; Group 3 = 21,033 p/sec/cm2, p<0.001) (Figure 1). At one week, all
groups continued to demonstrate significant increases in radiance from baseline
measurements (group 1 = 8,403 p/sec/cm2, p=0.0134; group 2 = 10,278 p/sec/cm2, p=0.0004
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group 3 = 16,837 p/sec/cm2, p<0.0001). By two weeks, no significant differences were
observed in radiance measurements between infected groups and baseline. While radiance
measurements between Groups 1 and 2 never differed significantly, Group 3 had statistically
higher radiance measurements compared to Groups 1 and 2 on days 0, 3, and 7.
Bioluminescence for each group peaked at day 3, and returned to baseline by day 21.
Unexpectedly, we noted several specimens that developed bioluminescence in subcutaneous
locations extending from the original injection site (Figure 2). Orthogonal IVIS imaging
confirmed that this bacterial spread was subcutaneous in location and did not violate
adjacent intervertebral disc spaces.
Histologic results

Author Manuscript

Samples processed using H&E, safranin-o and fast green, and gram staining were available
for analysis (Figure 4). H&E analysis revealed abscess formation defined by a
predominantly neutrophilic inflammatory infiltrate. Reactive bone formation in the context
of inflammation and repair was noted at the periphery of the intervertebral segments.
Safranin-O with fast green counterstain revealed complete destruction of the vertebral
endplate and adjacent physis. Gram staining revealed gram positive bacteria retained within
abscesses. Of note, bacteria were often found in association with necrotic bone fragments at
the core of the abscesses. Staining of control segments revealed preserved structure without
endplate disruption or inflammatory infiltration.
Radiologic results

Author Manuscript

At euthanasia, the affected vertebral segment was stiff to palpation, and therefore, Faxitron
radiographic imaging was performed to qualitatively assess osseous changes (Figure 5).
Infected segments showed no clear intervertebral disc space and formation of osteophytes,
consistent with evolving, but incomplete osseous bridging. To further assess osseous
changes at the affected segments, micro CT scan was performed on two specimens. Images
showed incomplete trabecular bridging, destruction of vertebral endplates, and sequestrum
formation (Figure 6). Control segments showed no radiographic changes.

Discussion

Author Manuscript

Despite a significant lack of consensus over the optimal route, duration, or class of
antibiotic, medical management of spondylodiscitis has remained the same for several
decades. The increasing number of patients with immunosuppression as well as the growing
incidence of antibiotic resistant bacteria emphasizes the expanding need for better
conservative management of spondylodiscitis. The present study describes a preclinical
model that permits objective, real-time, efficient evaluation of novel therapeutics for the
treatment of spondylodiscitis without the need to euthanize the animal to determine the
impact on infection.
To our knowledge, this is the first model of spondylodiscitis to use bioluminescent bacteria
for the visualization and quantification of intervertebral disc infection. This model has the
potential to improve the ability to increase study sample sizes while minimizing expenses of
spondylodiscitis studies. Established models of spine infection typically utilize larger
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animals and require paravertebral muscle dissection, intraoperative fluoroscopy, and
intensive anesthesia protocols15–24. Furthermore, these models require euthanasia at specific
time points to evaluate infection intensity. These factors increase the number of animals
required to execute infection studies, and as a result increase the associated costs of these
studies. Because this model uses a simple inoculation procedure and does not require
euthanasia to study therapeutic effect over time, the use of bioluminescent bacteria in rat
tails could significantly reduce these costs.
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In the present study, we simulated spondylodiscitis by injecting S. aureus directly into the
intervertebral disc. Detected bioluminescence was most intense at 7 days and returned to
baseline by 21 days. The decrease in bioluminescence at 21 days was likely due to depletion
of the nutrient environment, reduction in bacterial counts secondary to immunologic attack,
and sequestration of bacteria by the immune environment. Each group exhibited a spike in
bioluminescence between day 3 and 7 followed by a linear decline to baseline at day 21.
These findings indicate that seeding of the intervertebral disc is followed by a logarithmic
bacterial growth phase. As the infection expands and approaches immunologically active
vertebral endplates, planktonic bacteria is eliminated by host defenses. Additionally, bacteria
begin to form biofilm and enter a state of senescence, further decreasing the emitted
bioluminescent signal26; 28–31
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Another unique aspect of this model is the use of the rat tail vertebral column for the
simulation of spondylodiscitis. This location allows for easier inoculation and clinical
evaluation when compared to models that use a more proximal spinal section. Most cases of
clinical spondylodiscitis begin secondary to hematogenous seeding of the vertebral endplates
by way of metaphyseal arteries32. In this model, we injected bacteria directly into the disc to
induce infection. While this method of bacterial seeding differs from the pathologic etiology
in humans, our tissue analysis demonstrates histologic and radiographic findings similar to
clinical spondylodiscitis.
An unexpected finding was that retained bacteria within the core of intervertebral abscesses
were nearly always associated with necrotic bone. While we were also able to identify
sequestrum formation on micro CT, the finding of necrotic bone in proximity to retained
bacteria was distinct. The importance of this finding is as yet unclear, but suggests that
necrotic bone fragments might provide shelter for bacteria from immunologic defenses.

Author Manuscript

It is important to note that there are some limitations to this described model. First, we noted
bioluminescence in a subcutaneous location extending from the inoculation site. These
findings are consistent with the induction of a soft tissue infection, and is likely due to
extravasation of the inoculum from the injection site into surrounding tissues. Future
experiments using this model should use a smaller volume of inoculum and a smaller
injection needle to limit elution from the intervertebral disc. Second, because an injection
was used to introduce bacteria into the intervertebral disc space, the effects of the needle
puncture injury on disc architecture were not directly assessed. While established animal
models of disc degeneration use annular puncture to induce degeneration, we did not
observe these effects in our control segments. Recent studies suggest that the degeneration
associated with these injuries is based on needle gauge and that needle sizes similar to the
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ones in this study can be used for the delivery of therapeutics to the intradiscal environment
without inducing degeneration33; 34. Future studies could more fully characterize the
degenerative sequelae associated with the needle stick if undisturbed vertebral segments
were used as controls. Third, we noted the presence of bacteria at euthanasia despite the lack
of detected bioluminescent signal. This is likely due to bacterial counts that do not exceed
the threshold required for detection. While the concentrations of bacteria used in this study
are relevant for acute spondylodiscitis, this model is unlikely to adequately simulate an
indolent infection. Lastly, the present study did not include an interventional arm and, as a
result, further investigation is necessary to determine the ability of this model to detect
therapeutic effect. Although these are real limitations, histological and radiographic analysis
are consistent with a host reaction to spondylodiscitis, supporting the validity of this animal
model.

Author Manuscript

This model might also be enhanced by volumetric micro CT analysis of the tail vertebra as a
means to quantify changes in reactive bone formation, loss of intervertebral space, and
osteolysis between treated and untreated groups. Our qualitative micro CT analysis
demonstrated reactive bone formation and extensive osteolysis of adjacent vertebral
endplates. Indeed, prior rodent models of infection have demonstrated the utility of assessing
these differences between treatment and control groups as a proxy for therapeutic effect, and
quantitative analysis of these bony changes is likely to strengthen this model26; 37.
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Implementation of this model may ease the burden and associated expense of executing
preclinical studies of spondylodiscitis and facilitate investigations into antibiotic and novel
biologic treatments for the conservative management of spondylodiscitis. Although surgery
can be used to eradicate infections that fail medical management, the significant morbidity
associated with these procedures as well as the inability of surgery by itself to cure the
infection demands better biological interventions. The present study describes a preclinical
model that permits objective, real-time, and efficient evaluation of novel therapeutics for the
treatment of spondylodiscitis.
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Figure 1.

Bioluminescent results over time. Radiance returned to baseline by day 21 (left). Radiance
intensity overlaid on grayscale image of subjects (right).
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Figure 2.

Bioluminescent intensity map demonstrating subcutaneous spread of bacteria from site of
inoculation (A). Orthogonal imaging revealed that this signal originates from a subcutaneous
position (B).
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Figure 3.
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A: H&E staining of control intervertebral segments. Normal architecture is preserved. B:
H&E staining of infected intervertebral segment. Reactive bone formation (**), and abscess
(*) are noted. Original position of endplate is noted (<). C: Gram staining of infected
segment demonstrates abscesses (*) and reactive bone formation (**). D: Gram stain
demonstrates bacteria in proximity to necrotic bone. E: Safranin-O and fast green staining of
the control disc. F: Safranin-O staining of infected disc demonstrating endplate destruction
and trabecular bridging (arrow). Remnants of the cartilaginous endplate are noted (++).
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Figure 4.
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Faxitron imaging of infected and uninfected segments. No intervertebral space is noted at
the infected area (arrow).
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Figure 5.

Micro CT images of uninfected (A) and infected (B & C) segments. Reactive bone
formation is noted at the periphery of the infected segments. Partial trabecular bridging is
also noted. Sequestrum formation is evident near the endplate (C).
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Figure 6.

Percent radiance of recovered bacteria compared to stock solution. No significant differences
noted between groups.

Author Manuscript
Author Manuscript
J Orthop Res. Author manuscript; available in PMC 2018 September 01.

